Miguel Ibáñez

Miguel Ibáñez

Auto-generated profile, based on publicly available information

Miguel Ibáñez

Escuela Nacional de Ciencias Biológicas, IPN

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2019 in Current Stem Cell Research & Therapy
Verified
Journal Article
Closed access
PDF file
MTMariel E. Toledo-Guzmán
Mariel E. Toledo-Guzmán
MHMiguel Ibañez Hernández
Miguel Ibañez Hernández
ÁGÁngel A. Gómez-Gallegos
Ángel A. Gómez-Gallegos
EOElizabeth Ortiz-Sánchez
Elizabeth Ortiz-Sánchez
: Aldehyde dehydrogenase (ALDH) is an enzyme that participates in important cellular mechanisms as aldehyde detoxification and retinoic acid synthesis; moreover, ALDH activity is involved in drug resistance, a characteristic of cancer stem cells (CSCs). Even though ALDH is found in stem cells, CSCs and progenitor cells, this enzyme has been successfully used to identify and isolate cell populations with CSC properties from several tumor origins.: ALDH is allegedly involved in cell differentiation through its product, retinoic acid. However, direct or indirect ALDH inhibition, using specific inhibitors or retinoic acid, has shown a reduction in ALDH activity, along with the loss of stem cell traits, reduction of cell proliferation, invasion, and drug sensitization. For these reasons, ALDH and retinoic acid are promising therapeutic targets.: This review summarizes the current evidence for ALDH as a CSCs marker in solid tumors, as well as current knowledge about the functional roles of ALDH in CSCs. We discuss the controversy of ALDH activity to maintain CSC stemness, or conversely, to promote cell differentiation. Finally, we review the advances in using ALDH inhibitors as anti-cancer drugs.

30 July 2019 in Discover Nano
Verified
Journal Article
Open access
PDF file
PAPaulina Abrica-Gonzalez
Paulina Abrica-Gonzalez
JZJosé Alberto Zamora-Justo
José Alberto Zamora-Justo
ASAntonio Sotelo-López
Antonio Sotelo-López
GVGuillermo Rocael Vázquez-Martínez
Guillermo Rocael Vázquez-Martínez
JBJosé Abraham Balderas-López
José Abraham Balderas-López
MIMiguel Ibáñez-Hernández
Miguel Ibáñez-Hernández
Currently, gold nanoparticles have found applications in engineering and medical sciences, taking advantage from their properties and characteristics. Surface plasmon resonance, for instance, is one of the main features for optical applications and other physical properties, like high density, that represents the key for cellular uptake. Among other applications, in the medical field, some diseases may be treated by using gene therapy, including monogenetic or polygenetic disorders and infections. Gene adding, suppression, or substitution is one of the many options for genetic manipulation. This work explores an alternative non-viral method for gene transfer by using gold nanoparticles functionalized with organic polymers; two routes of synthesis were used: one of them with sodium borohydride as reducing agent and the other one with chitosan oligosaccharide as reducing and stabilizing agent. Gold nanoparticles conjugated with chitosan, acylated chitosan and chitosan oligosaccharide, were used to evaluate transfection efficiency of plasmid DNA into cell culture (HEK-293). Physical and chemical properties of gold nanocomposites were characterized by using UV-Vis Spectroscopy, ξ-potential, and transmission electron microscopy. Furthermore, the interaction between gold nanoparticles and plasmid DNA was demonstrated by using agarose gel electrophoresis. Transfection tests were performed and evaluated by β-galactosidase activity and green fluorescence protein expression. The percentage of transfection obtained with chitosan, acylated chitosan, and chitosan oligosaccharide were of 27%, 33%, and 60% respectively.

1 April 2006 in Life Sciences
Verified
Journal Article
Closed access
MDMargarita Díaz-Flores
Margarita Díaz-Flores
MIMiguel Angel Ibáñez-Hernández
Miguel Angel Ibáñez-Hernández
RGRosa Elba Galván
Rosa Elba Galván
MGMargarita Gutiérrez
Margarita Gutiérrez
GDGenoveva Durán-Reyes
Genoveva Durán-Reyes
LBLuis Arturo Baiza-Gutman
Luis Arturo Baiza-Gutman

26 December 2018 in World Journal of Stem Cells
Verified
Journal Article
Open access
MTMariel E Toledo-Guzmán
Mariel E Toledo-Guzmán
GBGabriele D Bigoni-Ordóñez
Gabriele D Bigoni-Ordóñez
MHMiguel Ibáñez Hernández
Miguel Ibáñez Hernández
ESElizabeth Ortiz Sánchez
Elizabeth Ortiz Sánchez
Cancer stem cell impact on clinical oncology

13 October 2019 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
JZJosé Alberto Zamora-Justo
José Alberto Zamora-Justo
PAPaulina Abrica-Gonzalez
Paulina Abrica-Gonzalez
GVGuillermo Rocael Vázquez-Martínez
Guillermo Rocael Vázquez-Martínez
AMAlejandro Muñoz-Diosdado
Alejandro Muñoz-Diosdado
JBJosé Abraham Balderas-López
José Abraham Balderas-López
MIMiguel Ibáñez-Hernández
Miguel Ibáñez-Hernández
The application of nanoscience and nanotechnology in medicine has been useful in the diagnosis, monitoring, and treatment of many diseases. Gold nanoparticles are commonly used for medical imaging studies, biosensors, drug delivery systems, and gene therapy. It has been reported that nanoparticles coated with specific polymers improve the biocompatibility and stability and decrease the cytotoxicity of the nanoparticles. In this work, we performed transfection studies of gold nanoparticles coated with polyethylene glycol, synthetized by two different methods, in a human embryonic kidney cell culture (HEK 293), by using plasmids pSV-β-Gal and pIRES2-EGFP. In addition, we also evaluated the cell uptake of a fluorescent drug (atorvastatin) using the synthetized gold nanoparticles as carriers. Furthermore, the study of cell viability after the interaction between these cells and the nanoparticles was performed. It was shown that the polyethylene glycol-coated gold nanoparticles presented transfection efficiency and cell uptake greater than 45% in each case. These results suggest that the synthetized gold nanoparticles coated with polyethylene glycol could be used successfully and safely as DNA and drug delivery systems.

1 September 1996 in Biochemistry and Cell Biology
Verified
Journal Article
Closed access
MIMiguel Ibáñez
Miguel Ibáñez
RSRosalba Santiago
Rosalba Santiago
CWCarlos Wong
Carlos Wong
IBIsabel Baeza
Isabel Baeza
PGPatricio Gariglio
Patricio Gariglio
PCPedro Chávez
Pedro Chávez
A new liposome system containing spermidine-condensed DNA and negative cone-forming lipids designed to improve gene delivery and expression is described. The compacted nature of condensed DNA forms permitted a higher extent of encapsulation of DNA in liposomes. These vesicles contained fusogenic cone-shaped lipids to increase fusion between liposomes and membranes to enhance the amount of DNA delivery into the cells. In addition, the insensitivity of condensed DNA forms to endonucleases and restriction enzymes, as well as their higher activity in both replication and transcription, improve foreign DNA expression. These improvements in condensed DNA encapsulation in liposomes, transfer into the cells, and DNA expression increase the number of transfected cells and produce a higher level of gene expression in most transfected cells. This is reflected in the 60-fold cell culture transfection increase compared with traditional liposome transfection systems. This liposome system does not cause any apparent damage to the transfected cells; furthermore, the liposomes are small, 400–500 nm, and have negative surface charges that can prolonge their circulation half-lives in vivo, permitting their use for in vivo gene therapy applications.Key words: gene transfer, liposome, spermidine-condensed DNA, cone-shaped lipids.